Progress in Myocardial Damage Detection: New Biochemical Markers for Clinicians

References

• Rude F E, Poole W K, Muller J E, et al. Electrocardiographic and clinical criteria for recognition of acute myocardial infarction based on analysis of 3697 patients. Am J Cardiol 1983; 52: 936–42
   PubMed Web of Science ®Google Scholar
• Graff L, Joseph T, Andelman R, et al. American college of emergency physicians information paper: chest pain units in emergency departments—a report from the short-term observation services section. Am J Cardiol 1995; 76: 1036–9
   Google Scholar
• Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, et al. (WHO MONICA Project). Myocardial infarction and coronary death in the World Health Organization MONICA Project—registration procedures, event rates, and case fatality rates in 38 populations from 21 countries in 4 continents. Circulation 1994; 90: 583–611
   PubMed Web of Science ®Google Scholar
• Jennings R B, Reimer K. A. The cell biology of acute myocardial ischemia. Annu Rev Med 1991; 42: 225–46
   PubMed Web of Science ®Google Scholar
• Di Lisa F, De Tullio R, Salamino F, et al. Specific degradation of troponin T and I by μ-calpain and its modulation by substrate phosphorylation. Biochem J 1995; 308: 57–61
   PubMed Web of Science ®Google Scholar
• Trump B F, Berezesky I. K. Calcium-mediated cell injury and cell death. FASEB J 1995; 9: 219–28
   PubMed Web of Science ®Google Scholar
• Gebhard M M, Denkhaus H, Sakai K, et al. Energy metabolism and enzyme release. J Mol Med 1977; 2: 271–83
   Google Scholar
• Piper H M, Schwartz P, Spahr R, et al. Early enzyme release from myocardial cells is not due to irreversible cell damage. J Mol Cell Cardiol 1984; 16: 385–8
   PubMed Web of Science ®Google Scholar
• Wienen W, Kammermeier H. Intra- and extracellular markers in interstitial transudate of perfused rat hearts. Am J Physiol 1988; 254: H785–94
   Google Scholar
• Heyndrickx G R, Amano J, Kennat, et al. Creatine kinase release not associated with myocardial necrosis after short periods of coronary artery occlusion in conscious baboons. J Am Coll Cardiol 1985; 6: 1299–1305
   PubMed Web of Science ®Google Scholar
• Michael L H, Hunt JR, Weilbach D. Creatine kinase and phosphorylase in cardiac lymph: coronary occlusion and reperfusion. Am J Physiol 1985; 248: 350–9
   Google Scholar
• Remppis A, Scheffold T, Greten J, et al. Intracellular compartmentation of troponin T: release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart. J Mol Cell Cardiol 1995; 27: 793–803
   PubMed Web of Science ®Google Scholar
• Spiekermann P G, Nordbeck H, Preusse CJ. From heart to plasma. Enzymes in cardiology: diagnosis and research, D J Hearse, J De Leiris. John Wiley, New York 1979; 59–79
   Google Scholar
• Van Kreel B, Van der Veen F H, Willems G M, et al. Circulatory models in assessment of cardiac enzyme release in dogs. Am J Physiol 1993; 264: H747–54
   Google Scholar
• Asayama J, Yamahara Y, Ohta B, et al. Release kinetics of cardiac troponin T in coronary effluent from isolated rat hearts during hypoxia and reoxygenation. Basic Res Cardiol 1992; 87: 428–36
   PubMed Web of Science ®Google Scholar
• Vorderwinkler K P, Mair J, Puschendorf B, et al. Cardiac troponin I increases in parallel to cardiac troponin T, creatine kinase and lactate dehydrogenase in effluents from isolated perfused rat hearts after hypoxia-reoxygenation-induced myocardial injury. Clin Chim Acta 1996; 251: 113–7
   Google Scholar
• Vork M M, Glatz J F, Surtel D A, et al. Release of fatty acid binding protein and lactate dehydrogenase from isolated rat heart during normoxia, low-flow ischemia, and reperfusion. Can J Physiol Pharmacol 1993; 71: 952–8
   PubMedGoogle Scholar
• Sunnergreen K P, Rovetto M. J. Microvascular permeability characteristics of isolated perfused ischemic rat heart. J Mol Cell Cardiol 1980; 12: 1011–31
   Google Scholar
• Dauber I M, VanBenthuysen K M, McMurty I F, et al. Functional coronary microvascular injury evident as increased permeability due to brief ischemia and reperfusion. Circ Res 1990; 66: 986–98
   PubMed Web of Science ®Google Scholar
• Mair J, Thome-Kromer B, Wagner I, et al. Concentration time courses of troponin and myosin subunits after acute myocardial infarction. Coronary Artery Dis 1994; 5: 865–72
   PubMed Web of Science ®Google Scholar
• Ladue J S, Wroblewski F, Karmen A. Serum glutamic oxaloacetic transaminase activity in human acute myocardial infarction. Science 1954; 120: 497–9
   PubMed Web of Science ®Google Scholar
• Goldmann Lee Th L. Serum enzyme assays in the diagnosis of acute myocardial infarction. Ann Intern Med 1986; 105: 221–33
   Google Scholar
• Adams JE, III, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s?. Circulation 1993; 88: 750–63
   PubMed Web of Science ®Google Scholar
• Mair J, Puschendorf B, Michel G. Clinical significance of cardiac contractile proteins for the diagnosis of myocardial injury. Adv Clin Chem 1994; 31: 63–98
   Google Scholar
• Wemer M, Brooks S H, Mohrbacher R J, et al. Diagnostic performance of enzymes in the discrimination of myocardial infarction. Clin Chem 1982; 28: 1297–1302
   Google Scholar
• van Kreel B K, van der Veen F H, Willems G M, et al. Circulatory models in assessment of cardiac enzyme release in dogs. Am J Physiol 1993; 264: H747–54
   Google Scholar
• van der Laarse A, Hermens W T, Hollaar L, et al. Assessment of myocardial damage in patients with acute myocardial infarction by serial measurement of serum alpha-hydroxybutyrate dehydrogenase levels. Am Heart J 1984; 107: 248–60
   Google Scholar
• van der Laarse A, Kerkhof P LM, Verneer F, et al. Relation between infarct size and left ventricular performance assessed in patients with first acute myocardial infarction randomized to intracoronary thrombolytic therapy or to conventional treatment. Am J Cardiol 1988; 61: 1–7
   Google Scholar
• Lee K N, Csako G, Bernhardt P, et al. Relevance of macro creatine kinase type 1 and 2 isoenzymes to laboratory and clinical data. Clin Chem 1994; 40: 1278–83
   PubMedGoogle Scholar
• Neumaier D. Tissue specific distribution of creatine kinase isoenzymes. Creatine kinase isoenzymes—pathophysiology and clinical application, H Lang. Springer-Verlag, Berlin 1981; 31–83
   Google Scholar
• Ingwall J S, Kramer M F, Fifer M A, et al. The creatine kinase system in normal and diseased human myocardium. N Engl J Med 1985; 313: 1050–4
   PubMed Web of Science ®Google Scholar
• Apple F S, Rogers M A, Shermann W M, et al. Profile of creatine kinase isoenzymes in skeletal muscle of marathon runners. Clin Chem 1984; 30: 413–6
   PubMed Web of Science ®Google Scholar
• Somer H, Duboeitz V, Donner M. Creatine kinase isoenzymes in neuromuscular diseases. J Neurol Sci 1976; 29: 129–36
   PubMedGoogle Scholar
• Chan K M, Ladenson J H, Pierce G F, et al. Increased creatine kinase MB in the absence of acute myocardial infarction. Clin Chem 1986; 32: 2044–51
   PubMedGoogle Scholar
• Mair J, Artner-Dworzak E, Dienstl A, et al. Early detection of acute myocardial infarction by measurement of mass concentration of creatine kinase-MB. Am J Cardiol 1991; 68: 1545–50
   PubMed Web of Science ®Google Scholar
• Mair J, Morandell D, Genser N, et al. Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction. Clin Chem 1995; 41: 1266–72
   PubMed Web of Science ®Google Scholar
• Gibler W B, Runyon J P, Levy R C, et al. A rapid diagnostic and treatment center for patients with chest pain in the emergency department. Ann Emerg Med 1995; 25: 1–8
   PubMed Web of Science ®Google Scholar
• Laperche T, Steg P G, Dehoux M, et al. A study of biochemical markers of reperfusion early after thrombolysis for acute myocardial infarction. Circulation 1995; 92: 2079–86
   PubMed Web of Science ®Google Scholar
• Ravkilde J, Nissen H, Horder M, et al. Independent prognostic value of serum creatine kinase isoenzyme MB mass, cardiac troponin T and myosin light chain levels in suspected myocardial infarction. J Am Coll Cardiol 1995; 25: 574–81
   PubMed Web of Science ®Google Scholar
• Puleo P R, Guadagno P A, Roberts R, et al. Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB. Circulation 1990; 82: 759–64
   PubMedGoogle Scholar
• Kanemitsu F, Okigaki T. A combination assay of MB and MM isoforms of serum creatine kinase in acute myocardial infarction. Clin Chim Acta 1994; 229: 161–9
   Google Scholar
• Bhayana V, Cohoe S, Leung F Y, et al. Diagnostic evaluation of creatine kinase-2 mass and creatine kinase-3 and -2 isoform ratios in early diagnosis of acute myocardial infarction. Clin Chem 1993; 39: 488–95
   PubMedGoogle Scholar
• Erdös E G, Skidgel R. A. More on subforms of creatine kinase MB (letter). N Engl J Med 1995; 333: 390
   PubMedGoogle Scholar
• Wu J T, Pieper R K, Wu L H, et al. Isolation and characterization of myoglobin and its two major isoforms from sheep heart. Clin Chem 1989; 35: 778–782
   Google Scholar
• Stone M J, Willerson J T, Gomez-Sanchez C E, et al. Radioimmunoassay of myoglobin in human serum. Results in patients with acute myocardial infarction. J Clin Invest 1975; 56: 1334–9
   PubMed Web of Science ®Google Scholar
• Delanghe J, Chapelle JP, Vanderschueren S. Quantitative nephelometric assay for determining myoglobin evaluated. Clin Chem 1990; 36: 1675–8
   PubMedGoogle Scholar
• Mair J, Artner-Dworzak E, Lechleitner P, et al. Early diagnosis of acute myocardial infarction by a newly developed rapid immunoturbidimetric assay for myoglobin. Br Heart J 1992; 68: 462–8
   PubMedGoogle Scholar
• de Winter R J, Koster R W, Sturk A, et al. Value of myoglobin, troponin T, and CKMB mass in ruling out an acute myocardial infarction in the emergency room. Circulation 1995; 92: 3401–8
   PubMed Web of Science ®Google Scholar
• Klocke F J, Copley D P, Krawczyk J A, et al. Rapid renal clearance of immunoreactive canine plasma myoglobin. Circulation 1982; 65: 1522–8
   PubMed Web of Science ®Google Scholar
• Honda Y, Katayama T. Detection of myocardial infarction extension or reattack by serum myoglobin radioimmunoassay. Int J Cardiol 1984; 6: 325–35
   PubMed Web of Science ®Google Scholar
• Mair P, Mair J, Seibt I, et al. Early and rapid diagnosis of perioperative myocardial infarction in aortocoronary bypass surgery by immunoturbidimetric myoglobin measurements. Chest 1993; 103: 1508–11
   Google Scholar
• Cooke R. The actomyosin engine. FASEB J 1995; 9: 636–42
   PubMed Web of Science ®Google Scholar
• Farah C S, Reinach F. C. The troponin complex and regulation of muscle contraction. FASEB J 1995; 9: 755–67
   PubMed Web of Science ®Google Scholar
• Raggi A, Grand R JA, Moir A JG, et al. Structure-function relationships in cardiac troponin T. Biochim Biophys Acta 1989; 997: 135–43
   PubMedGoogle Scholar
• Pharmacek M S, Leiden JM. Structure, function and regulation of troponin C. Circulation 1991; 84: 991–1003
   PubMed Web of Science ®Google Scholar
• Yamauchi-Takihara K, Sole M J, Liew J., et al. Characterization of human cardiac myosin heavy chain genes. Proc Natl Acad Sci USA 1989; 86: 3504–8
   PubMedGoogle Scholar
• Barton P JR, Cohen A, Robert B, et al. The myosin alkali light chains of mouse ventricular and slow skeletal muscle are indistinguishable and are encoded by the same gene. J Biol Chem 1984; 260: 8578–84
   Google Scholar
• Collins J H, Theibert JL, Libera LD. Amino acid sequence of rabbit ventricular myosin light chain-2: identity with slow skeletal muscle isoform. Biosci Rep 1986; 6: 655–71
   Google Scholar
• Schwartz K, Boheler K R, de la Bastie D, et al. Switches in cardiac muscle gene expression as a result of pressure and volume overload. Am J Physiol 1992; 262: R364–9
   Google Scholar
• Cummins P. The homology of the alpha chains of cardiac and skeletal rabbit tropomyosin. J Mol Cell Cardiol 1979; 11: 109–14
   PubMedGoogle Scholar
• Pearlstone J, Carpenter M, Smillie L. Amino acid sequences of rabbit cardiac troponin. T. J Biol Chem 1986; 261: 16795–810
   PubMedGoogle Scholar
• Wilkinson J M, Grand R JA. Comparison of amino acid sequence of troponin I from different striated muscles. Nature 1978; 271: 31–5
   PubMed Web of Science ®Google Scholar
• Anderson P AW, Malouf N N, Oakeley A E, et al. Troponin T isoform expression in humans. A comparison among normal and failing adult heart, fetal heart, and adult and fetal skeletal muscle. Circ Res 1991; 69: 1226–33
   PubMed Web of Science ®Google Scholar
• Katus H A, Looser S, Hallermayer K, et al. Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem 1992; 38: 386–93
   PubMed Web of Science ®Google Scholar
• Katus H A, Remppis A, Scheffold T, et al. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction. Am J Cardiol 1991; 67: 1360–7
   PubMed Web of Science ®Google Scholar
• Kragten J A, Hermens WT, Dieijen-Visser MP. Cardiac troponin T release into plasma after acute myocardial infarction: only fractional recovery compared with enzymes. Ann Clin Biochem 1996; 33: 314–23
   PubMedGoogle Scholar
• Saggin L, Gorza L, Ausoni S, et al. Cardiac troponin T in developing, regenerating and denerved rat skeletal muscle. Development 1990; 110: 547–54
   PubMed Web of Science ®Google Scholar
• Bodor G, Porterfield D, Voss E, et al. Cardiac troponin T composition in regenerating human skeletal muscle tissue (Abstr.). Clin Chem 1995; 41: 148
   Google Scholar
• Mair J, Artner-Dworzak E, Lechleitner P, et al. Cardiac troponin T in diagnosis of acute myocardial infarction. Clin Chem 1991; 37: 845–52
   PubMed Web of Science ®Google Scholar
• Katus H A, Remppis A, Neumann F L, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991; 83: 902–12
   PubMed Web of Science ®Google Scholar
• Westfall M V, Solaro RJ. Alterations in myofibrillar function and protein profiles after complete global ischemia in rat hearts. Circ Res 1990; 70: 302–13
   Google Scholar
• Wagner I, Mair J, Fridrich L, et al. Cardiac troponin T release in acute myocardial infarction is associated with scintigraphic estimates of myocardial scar. Coronary Artery Dis 1993; 4: 537–44
   Google Scholar
• Omura T, Teragaki M, Tani T, et al. Estimation of infarct size using serum troponin T concentration in patients with acute myocardial infarction. Jpn Circ J 1993; 57: 1062–70
   PubMedGoogle Scholar
• Lee T H, Thomas E J, Ludwig L E, et al. Troponin T as a marker for myocardial ischemia in patients undergoing major noncardiac surgery. Am J Cardiol 1996; 77: 1031–6
   PubMed Web of Science ®Google Scholar
• Mair P, Mair J, Seibt I, et al. Cardiac troponin T: a new marker of myocardial tissue damage in bypass surgery. J Cardiothorac Vase Anesth 1993; 7: 674–8
   Google Scholar
• Hake U, Schmid F X, Iversen S, et al. Troponin T — a reliable marker of perioperative myocardial infarction. Eur J Cardiothorac Surg 1993; 7: 628–33
   PubMedGoogle Scholar
• Hamm C W, Ravkilde J, Gerhardt W, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992; 327: 146–50
   PubMed Web of Science ®Google Scholar
• Lindahl B, Venge P, Wallentin L, et al. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996; 93: 1651–7
   PubMed Web of Science ®Google Scholar
• Genser N, Mair J, Friedrich G, et al. Uncomplicated successful percutaneous transluminal coronary angioplasty does not affect cardiac troponin T plasma concentrations (letter). Am J Cardiol 1996; 78: 127–8
   PubMed Web of Science ®Google Scholar
• Ravkilde J, Nissen H, Mickley H, et al. Cardiac troponin T and CKMB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris. Am Heart J 1994; 127: 13–20
   Google Scholar
• Bachmaier K, Mair J, Offner F, et al. Serum cardiac troponin T and creatine kinase-MB elevations in murine autoimmune myocarditis. Circulation 1995; 92: 1927–32
   PubMedGoogle Scholar
• Franz W M, Remppis A, Kandolf R, et al. Serum troponin T: diagnostic marker for acute myocarditis (letter). Clin Chem 1996; 42: 340–1
   PubMedGoogle Scholar
• Walpoth B H, Tschopp A, Perheim E, et al. Assessment of troponin T for detection of cardiac rejection in a rat model. Transplant Proc 1995; 27: 2084–7
   PubMedGoogle Scholar
• Zimmermann R, Baki S, Dengler T J, et al. Troponin T release after heart transplantation. Br Heart J 1993; 69: 395–8
   Google Scholar
• Riou B, Dreux S, Roche S, et al. Circulating cardiac troponin T in potential heart transplant donors. Circulation 1995; 92: 409–14
   Google Scholar
• Mair P, Mair J, Koller J, et al. Cardiac troponin T release in multiple injured patients. Injury 1995; 26: 439–43
   Google Scholar
• Katus H A, Müller-Bardorff M, Hallermayer K, et al. The second generation of the cardiac troponin T ELISA: improved specificity (Abstr.). Clin Chem 1995; 41: S79
   Google Scholar
• Kobayashi S, Tanaka M, Tamura N, et al. Serum cardiac troponin T in polymyositis/dermatomyositis (letter). Lancet 1992; 340: 726
   PubMedGoogle Scholar
• Thome-Kromer B, Michel G. Human cardiac troponin I — detectability after myocardial infarction and severe skeletal muscle damage (Abstr.). Clin Chem 1993; 39: 1248
   Google Scholar
• Hafner G, Thome-Kromer B, Schaube J, et al. Cardiac troponins in serum in chronic renal failure (letter). Clin Chem 1994; 40: 1790–1
   PubMed Web of Science ®Google Scholar
• Collinson P O, Stubbs PJ, Rosalki SB. Cardiac troponin T in renal disease (letter). Clin Chem 1995; 41: 1671–3
   PubMedGoogle Scholar
• Vallins W J, Brand N J, Dabjade N, et al. Molecular cloning of human troponin I using polymerase chain reaction. FEBS Lett 1990; 270: 57–61
   PubMed Web of Science ®Google Scholar
• Saggin L, Gorza L, Ausoni S, et al. Troponin I switching in the developing heart. J Biol Chem 1989; 264: 16299–302
   PubMed Web of Science ®Google Scholar
• Bhavsar P, Dhoot G K, Cumming D VE, et al. Developmental expression of troponin I isoforms in fetal human heart. FEBS Lett 1991; 292: 5–8
   Google Scholar
• Cummins B, Auckland ML, Cummins P. Cardiac-specific troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction. Am Heart J 1987; 113: 1333–44
   PubMed Web of Science ®Google Scholar
• Bodor G S, Porterfield D, Voss E M, et al. Cardiac troponin I is not expressed in fetal and healthy and diseased adult human skeletal muscle tissue. Clin Chem 1995; 41: 1710–5
   PubMed Web of Science ®Google Scholar
• Adams JE, III, Schechtman K B, Landt Y, et al. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. Clin Chem 1994; 40: 1291–5
   PubMed Web of Science ®Google Scholar
• Mair J, Genser N, Morandell D, et al. Cardiac troponin I in the diagnosis of myocardial injury and infarction. Clin Chim Acta 1996; 245: 19–38
   PubMed Web of Science ®Google Scholar
• Larue C, Calzolari C, Bertinchant J P, et al. Cardiac-specific immunoenzymometric assay of troponin I in the early phase of acute myocardial infarction. Clin Chem 1993; 39: 972–9
   PubMed Web of Science ®Google Scholar
• Apple F S, Henry T D, Berger C R, et al. Early monitoring of serum cardiac troponin I for assessment of coronary reperfusion following thrombolytic therapy. Am J Clin Pathol 1996; 105: 6–10
   PubMedGoogle Scholar
• Mair J, Wagner I, Morass B, et al. Cardiac troponin I release correlates with myocardial infarction size. Eur J Clin Chem Clin Biochem 1995; 33: 869–72
   PubMedGoogle Scholar
• Wu A HB, Feng YI, Contois JH. Prognostic value of cardiac troponin I in chest pain patients (letter). Clin Chem 1996; 42: 651–2
   Google Scholar
• Hunt A C, Chow S L, Shiu M F, et al. Release of creatine kinase-MB and cardiac specific troponin-I following percutaneous transluminal coronary angioplasty. Eur Heart J 1991; 12: 690–4
   PubMedGoogle Scholar
• Adams JE, III, Sicard G A, Allen B T, et al. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. N Engl J Med 1994; 330: 670–4
   PubMed Web of Science ®Google Scholar
• Mair J, Larue C, Mair P, et al. Use of cardiac troponin I to diagnose perioperative myocardial infarction in coronary artery bypass grafting. Clin Chem 1994; 40: 2066–70
   PubMedGoogle Scholar
• Smith S C, Ladenson J H, Mason J W, et al. Detection of myocarditis by cardiac troponin I (Abstr.). Circulation 1994; 90: 547, Suppl. I
   Google Scholar
• Grant J W, Canter C E, Spray T L, et al. Elevated donor cardiac troponin I — a marker of acute graft failure in infant heart recipients. Circulation 1994; 90: 2618–21
   Google Scholar
• Adams JE, III, Davila-Roman V G, Bossey P Q, et al. Improved detection of cardiac contusion with cardiac troponin I. Am Heart J 1996; 131: 308–12
   Web of Science ®Google Scholar
• Adams JE, III, Bodor G S, Davila-Roman V G, et al. Cardiac troponin I — a marker with high specificity for cardiac injury. Circulation 1993; 88: 101–6
   PubMed Web of Science ®Google Scholar
• Trinquier S, Flecheux O, Bullenger M, et al. Highly specific immunoassay for cardiac troponin I assessed in noninfarct patients with chronic renal failure or severe polytrauma (letter). Clin Chem 1995; 41: 1676
   Google Scholar
• Khaw BA, Gold H K, Fallon J T, et al. Detection of serum cardiac myosin light chains in acute experimental myocardial infarction: radioimmunoassay of cardiac myosin light chains. Circulation 1978; 58: 1130–6
   Google Scholar
• Gere J B, Kxauth G H, Trahem C A, et al. A radioimmunoassay for the measurement of human cardiac light chains. Am J Clin Pathol 1979; 71: 309–18
   PubMedGoogle Scholar
• Mair J, Puschendorf B. Myocardial injury: laboratory diagnosis. Springer, Heidelberg 1996; 114–8
   Google Scholar
• Mair J, Wagner I, Jakob G, et al. Different time courses of cardiac contractile proteins after acute myocardial infarction. Clin Chim Acta 1994; 231: 47–60
   PubMed Web of Science ®Google Scholar
• Katus H A, Yasada T, Gold H K, et al. Diagnosis of acute myocardial infarction by detection of circulating cardiac myosin light chains. Am J Cardiol 1984; 54: 964–70
   PubMedGoogle Scholar
• Katus HA, Diederich K W, Schwarz F, et al. Influence of reperfusion on serum concentrations of cytosolic creatine kinase and structural myosin light chains in acute myocardial infarction. Am J Cardiol 1987; 60: 440–5
   PubMed Web of Science ®Google Scholar
• Isobe M, Nagai R, Ueda S, et al. Quantitative relationship between left ventricular function and serum cardiac myosin light chain I levels after coronary reperfusion in patients with acute myocardial infarction. Circulation 1987; 76: 1251–61
   Google Scholar
• Mair J, Wagner I, Fridrich L, et al. Cardiac myosin light chain-1 release in acute myocardial infarction is associated with scintigraphic estimates of myocardial scar. Clin Chim Acta 1994; 229: 153–9
   Google Scholar
• Omura T, Teregaki M, Tagaki M, et al. Myocardial infarct size by serum troponin T and myosin light chain-1 concentration. Jpn Circ J 1995; 59: 154–9
   PubMedGoogle Scholar
• Nakai K, Itoh C, Kikuchi M, et al. Increased serum levels of human cardiac myosin light chain 1 in patients with renal failure. Rinsho Byori 1992; 40: 529–34
   Google Scholar
• Fukunaga H, Higuchi I, Usuki F, et al. Clinical significance of serum cardiac myosin light chain 1 in patients with Duchenne muscular dystrophy. No To Shinkei 1992; 44: 131–5
   Google Scholar
• Diederich K W, Eisele I, Ried T, et al. Isolation and characterization of the complete human beta-myosin heavy chain gene. Hum Genet 1989; 81: 214–20
   PubMedGoogle Scholar
• Bredman J J, Wessels A, Weijs W A, et al. Demonstration of “cardiac-specific” myosin heavy chain in masticatory muscles of human and rabbit. Histochem J 1991; 23: 160–70
   PubMedGoogle Scholar
• Larue C, Calzolari C, Leger J, et al. Immunoradiometric assay of myosin heavy chain fragments in plasma for investigation of myocardial infarction. Clin Chem 1991; 37: 78–82
   PubMed Web of Science ®Google Scholar
• Simeonova P P, Kehayov IR, Kyurkchiev SD. Identification of human ventricular myosin heavy chain fragments with monoclonal antibody 2F4 in human sera after myocardial necrosis. Clin Chim Acta 1991; 201: 207–22
   PubMedGoogle Scholar
• Leger J OC, Larue C, Ming T, et al. Assay of serum cardiac myosin heavy chain fragments in patients with acute myocardial infarction: determination of infarct size and long-term follow-up. Am Heart J 1990; 120: 781–90
   PubMedGoogle Scholar
• Mair J, Puschendorf B. Myocardial injury: laboratory diagnosis. Springer, Heidelberg 1996; 110–4
   Google Scholar
• Mair J, Puschendorf B. Myocardial injury: laboratory diagnosis. Springer, Heidelberg 1996; 79–80
   Google Scholar
• Rabitzsch G, Mair J, Lechleitner P, et al. Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury. Clin Chem 1995; 41: 966–78
   PubMed Web of Science ®Google Scholar
• Krause E G, Rabitzsch G, Noll F, et al. Glycogen phosphorylase isoenzyme BB in diagnosis of myocardial ischaemic injury and infarction. 1996, Mol Cell Biochem (in press)
   Google Scholar
• Krause E G, Härtwig A, Rabitzsch G. On the release of glycogen phosphorylase from heart muscle: effect of substrate depletion, ischemia, and of imipramine. Biomed Biochim Acta 1989; 48: S77–S82
   Google Scholar
• Newgard C B, Hwang PK, Fletterick RJ. The family of glycogenphosphorylases: structure and function. Crit Rev Biochem Mol Biol 1989; 24: 69–99
   PubMed Web of Science ®Google Scholar
• Mair J, Puschendorf B, Smidt J, et al. Early release of glycogen phosphorylase in patients with unstable angina and transient ST-T alterations. Br Heart J 1994; 72: 125–7
   PubMedGoogle Scholar
• Mair P, Mair J, Krause E-G, et al. Glycogen phosphorylase isoenzyme BB mass release after coronary artery bypass grafting. Eur J Clin Chem Clin Biochem 1994; 34: 543–7
   Google Scholar
• Kleine A H, Glatz J FK, van Nieuwenhoven F A, et al. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 1992; 116: 155–62
   PubMed Web of Science ®Google Scholar
• Glatz J FC, van der Vusse GJ. Cellular fatty acid-binding proteins: current concepts and future directions. Mol Cell Biochem 1990; 98: 237–51
   Google Scholar
• Kragten J A, van Nieuwenhoven F A, van Dieijen-Visser M P, et al. Distribution of myoglobin and fatty acid binding protein in human heart (letter). Clin Chem 1996; 42: 337–8
   PubMedGoogle Scholar
• Roos W, Eymann E, Symannek M, et al. Monoclonal antibodies to human heart fatty acid-binding protein. J Immunol Methods 1995; 183: 149–53
   PubMed Web of Science ®Google Scholar
• Ohkaru Y, Asayama K, Ishii H, et al. Developmental of a sandwich enzymelinked immunosorbent assay for the determination of human heart-type fatty acid-binding protein in plasma and urine by using two different monoclonal antibodies specific for human heart fatty acid-binding protein. J Immunol Methods 1995; 178: 99–111
   PubMed Web of Science ®Google Scholar
• Watanabe K, Wakabayashi H, Veerkamp J H, et al. Immunohistochemical distribution of heart-type fatty acid binding protein immunoreactivity in normal human tissues and in acute myocardial infarct. J Pathol 1993; 170: 59–65
   PubMed Web of Science ®Google Scholar
• Van Nieuwenhoven F A, Kleine A H, Wodzig K WH, et al. Discrimination between myocardial and skeletal muscle injury by assessment of plasma ratio of myoglobin over fatty acid binding protein. Circulation 1995; 92: 2848–54
   PubMed Web of Science ®Google Scholar
• Glatz J FC, Kleine A H, van Nieuwenhoven F A, et al. Fatty-acid binding protein as a plasma marker for the estimation of myocardial infarct size in humans. Br Heart J 1994; 71: 135–10
   PubMedGoogle Scholar
• Tsuji R, Tanaka T, Sohmiya K, et al. Human heart-type cytoplasmic fatty acid binding protein in serum and urine during hyperacute myocardial infarction. Int J Cardiol 1993; 41: 209–17
   PubMed Web of Science ®Google Scholar
• Jeffery S, Carter N, Edwards Y. Distribution of CA III in fetal and adult human tissue. Biochem Genet 1980; 18: 843–9
   PubMed Web of Science ®Google Scholar
• Sly W S, Hu PY. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem 1995; 64: 375–401
   PubMed Web of Science ®Google Scholar
• Väänänen H K, Syrjälä H, Rahkila P, et al. Serum carbonic anhydrase III and myoglobin concentrations in acute myocardial infarction. Clin Chem 1990; 36: 635–8
   PubMed Web of Science ®Google Scholar
• Vuori J, Syrjälä H, Väänänen HK. Myoglobin/carbonic anhydrase III ratio: highly specific and sensitive early indicator for myocardial damage in acute myocardial infarction. Clin Chem 1996; 42: 107–9
   PubMed Web of Science ®Google Scholar
• Kato K, Kimura S, Haimoto H, et al. S100a0 (αα) protein: distribution in muscle tissue of various animals and purification from human pectoral muscle. J Neurochem 1986; 46: 1555–60
   PubMedGoogle Scholar
• Kato K, Kimura S. S100a0 protein is mainly located in the heart and striated muscles. Biochim Biophys Acta 1985; 842: 146–50
   PubMed Web of Science ®Google Scholar
• Usui A, Kato K, Sasa H, et al. S-100a0 protein in serum during acute myocardial infarction. Clin Chem 1990; 36: 639–41
   Google Scholar
• Usui A, Kato K, Abe T, et al. S-100 protein in blood and urine during open heart surgery. Clin Chem 1989; 35: 1942–4
   PubMed Web of Science ®Google Scholar
• Kaneko N, Matsuda R, Hosoda S, et al. Measurement of plasma annexin V by ELISA in the early detection of acute myocardial infarction. Clin Chim Acta 1996; 251: 65–80
   PubMedGoogle Scholar
• Kato K, Ishiguro Y, Ariyoshi Y. Enolase isoenzymes as disease markers: distribution of three enolase subunits (α, β and γ) in various human tissues. Dis Markers 1983; 1: 213–20
   Google Scholar
• Nomura M, Kato K, Nagasaka A, et al. Serum β-enolase in acute myocardial infarction. Br Heart J 1987; 58: 29–33
   Google Scholar
• Herraz-Dominguez M, Goldberg D, Anderson A, et al. Serum enolase and pyruvate kinase activities in the diagnosis of myocardial infarction. Enzyme 1976; 21: 211–24
   Google Scholar
• Usui A, Kato K, Abe T, et al. β-Enolase in blood plasma during open heart surgery. Cardiovasc Res 1989; 23: 737–40
   Google Scholar
• Uchida K, Kondoh K, Matuo Y. Recombinant M-, B-, and MB-type isozymes of human phosphoglyceric acid mutase: their large-scale production and preparation of polyclonal antibodies specific to M- and B-type isozymes. Clin Chim Acta 1995; 237: 43–58
   PubMed Web of Science ®Google Scholar
• Omenn G S, Cheung S CY. Phosphoglycerate mutase isozyme marker for tissue differentiation in man. Am J Hum Genet 1974; 26: 393–9
   PubMedGoogle Scholar
• Stewart R E, O'Neill WW. Direct angioplasty for acute myocardial infarction. Curr Opin Cardiol 1995; 10: 367–71
   Google Scholar
• Madias JE. Acute myocardial infarction: shifting paradigms of diagnosis and care in cost-conscous environment. Chest 1995; 108: 1483–5
   Google Scholar
• Zabel M, Hohnloser S H, Köster W, et al. Analysis of creatine kinase, CK-MB, myoglobin, and troponin T time-activity curves for early assessment of coronary artery reperfusion after intravenous thrombolysis. Circulation 1993; 87: 1542–50
   PubMed Web of Science ®Google Scholar
• Grover A, Rihal CS. The importance of early patency after acute myocardial infarction. Curr Opin Cardiol 1995; 10: 361–6
   PubMedGoogle Scholar
• Doevendans P A, Gorgels A P, van der Zee R, et al. Electrocardiographic diagnosis of reperfusion during thrombolytic therapy in acute myocardial infarction. Am J Cardiol 1995; 75: 1206–10
   Google Scholar
• McKendall G R, Forman S, Sopko G, et al. Value of rescue percutaneous transluminal coronary angioplasty following unsuccessful thrombolytic therapy in patients with acute myocardial infarction. Am J Cardiol 1995; 76: 1108–11
   Google Scholar
• Aguirre F V, Merritt RF, Carollo SC. The role of coronary angiography after thrombolysis. Curr Opin Cardiol 1995; 10: 381–8
   Google Scholar
• Mair J, Smidt J, Lechleitner P, et al. A decision tree for the early diagnosis of acute myocardial infarction in non-traumatic chest pain patients at hospital admission. Chest 1995; 108: 1502–9
   PubMedGoogle Scholar
• Bakker A J, Koelemay M JW, Gorgels J PMC, et al. Failure of new biochemical markers to exclude acute myocardial infarction at admission. Lancet 1993; 342: 1220–2
   PubMed Web of Science ®Google Scholar
• Roberts R, Kleiman NS. Earlier diagnosis and treatment of acute myocardial infarction necessitates the need for a “new diagnostic mind-set”. Circulation 1994; 89: 872–81
   PubMed Web of Science ®Google Scholar
• Ohman E M, Armstrong P, Califf R M, et al. Risk stratification in acute ischaemic syndromes using serum troponin T. J Am Coll Cardiol 1995; 25: 148A
   Google Scholar
• Betriu A, Heras M, Cohen M, et al. Unstable angina: outcome according to clinical presentation. J Am Coll Cardiol 1992; 19: 1659–63
   PubMed Web of Science ®Google Scholar
• Rizik D, Healy G. S, Margulis A, et al. A new clinical classification for hospital prognosis of unstable angina pectoris. Am J Cardiol 1995; 75: 993–7
   PubMedGoogle Scholar
• Feghali N T, Prisant ML. Blunt cardiac injury. Chest 1995; 108: 1673–7
   Google Scholar
• Katus HA. Ischaemic myocardial damage early detection: biochemical markers. Oral communication. Eur Soc Cardiol Symp. Sophia AntipolisFrance February, 1996
   Google Scholar
• Mair J., Unpublished results
   Google Scholar